Literature DB >> 21269274

Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.

Xiaohua Yan1, Ye-Guang Chen.   

Abstract

TGF-β (transforming growth factor-β) is a pleiotropic cytokine regulating diverse cellular processes. It signals through membrane-bound receptors, downstream Smad proteins and/or other signalling mediators. Smad7 has been well established to be a key negative regulator of TGF-β signalling. It antagonizes TGF-β signalling through multiple mechanisms in the cytoplasm and in the nucleus. Smad7 can be transcriptionally induced by TGF-β and other growth factors and serves as an important cross-talk mediator of the TGF-β signalling pathway with other signalling pathways. Accordingly, it plays pivotal roles in embryonic development and adult homoeostasis, and altered expression of Smad7 is often associated with human diseases, such as cancer, tissue fibrosis and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269274     DOI: 10.1042/BJ20101827

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  97 in total

1.  Differentiated intestinal epithelial cells express high levels of TGF-β receptors and exhibit increased sensitivity to growth inhibition.

Authors:  Navneeta Rathor; Shelley R Wang; Elizabeth T Chang; Jaladanki N Rao
Journal:  Int J Clin Exp Med       Date:  2011-11-10

2.  Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis.

Authors:  Haloom Rafehi; Andrea J Smith; Aneta Balcerczyk; Mark Ziemann; Jenny Ooi; Shanon J Loveridge; Emma K Baker; Assam El-Osta; Tom C Karagiannis
Journal:  Genes Nutr       Date:  2011-09-28       Impact factor: 5.523

3.  Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation.

Authors:  Christopher Riling; Hari Kamadurai; Suresh Kumar; Claire E O'Leary; Kuen-Phon Wu; Erica E Manion; Mingjie Ying; Brenda A Schulman; Paula M Oliver
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

4.  Cyclic AMP Response Element-binding Protein H (CREBH) Mediates the Inhibitory Actions of Tumor Necrosis Factor α in Osteoblast Differentiation by Stimulating Smad1 Degradation.

Authors:  Won-Gu Jang; Byung-Chul Jeong; Eun-Jung Kim; Hyuck Choi; Sin-Hye Oh; Don-Kyu Kim; Seung-Hoi Koo; Hueng-Sik Choi; Jeong-Tae Koh
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

5.  Tril targets Smad7 for degradation to allow hematopoietic specification in Xenopus embryos.

Authors:  Yangsook Song Green; Sunjong Kwon; Mizuho S Mimoto; Yuanyuan Xie; Jan L Christian
Journal:  Development       Date:  2016-09-15       Impact factor: 6.868

Review 6.  Primary Cilia and Coordination of Receptor Tyrosine Kinase (RTK) and Transforming Growth Factor β (TGF-β) Signaling.

Authors:  Søren T Christensen; Stine K Morthorst; Johanne B Mogensen; Lotte B Pedersen
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

7.  SMAD7, an antagonist of TGF-beta signaling, is a candidate of prenatal skeletal muscle development and weaning weight in pigs.

Authors:  Chaoju Hua; Zishuai Wang; Jianbing Zhang; Xing Peng; Xinhua Hou; Yalan Yang; Kui Li; Zhonglin Tang
Journal:  Mol Biol Rep       Date:  2016-02-22       Impact factor: 2.316

Review 8.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

9.  Expression of USP15, TβR-I and Smad7 in psoriasis.

Authors:  Ai-Ping Feng; Yi-Min He; Xin-Xin Liu; Jia-Wen Li; Ya-Ting Tu; Feng Hu; Shan-Juan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

Review 10.  SMAD7: a timer of tumor progression targeting TGF-β signaling.

Authors:  Lingyu Luo; Nianshuang Li; Nonghua Lv; Deqiang Huang
Journal:  Tumour Biol       Date:  2014-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.